Clinical Trial: Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
Study Status: Completed
Recruit Status: RECRUITING
Condition: Invasive Mammary Carcinoma
Study Type: INTERVENTIONAL
Official Title: Integrating Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort (INSIGHT)
Brief Summary:
This is an open-label, multicenter, two-arm Phase II clinical trial that will evaluate the impact of 2nd line chemotherapy (i.e.capecitabine) on survival in patients with non-Luminal A hormone receptor-positive (HR+) metastatic breast cancer (MBC)
Read more